// App-Quantinova.ai

2062 : Nanoemulsion formulations for anticancer agent piplartine characterization, toxicological, pharmacokinetics and efficacy studies

Researchers

Presenter

  • Neel Fofaria

Principal Investigators

  • Alok Ranjan

  • Hussaini Syed Sha Qhattal

  • Xinli Liu

  • Sanjay K. Srivastava

Medical Centers

  • Texas Tech Univ. Health Sciences Ctr., Amarillo, TX.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved